Last reviewed · How we verify
Arthcal BAKUCHIOL FACE SERUM — Competitive Intelligence Brief
marketed
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Arthcal BAKUCHIOL FACE SERUM (BAKUCHIOL) — Beijing JUNGE Technology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Arthcal BAKUCHIOL FACE SERUM TARGET | BAKUCHIOL | Beijing JUNGE Technology Co., Ltd. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Arthcal BAKUCHIOL FACE SERUM CI watch — RSS
- Arthcal BAKUCHIOL FACE SERUM CI watch — Atom
- Arthcal BAKUCHIOL FACE SERUM CI watch — JSON
- Arthcal BAKUCHIOL FACE SERUM alone — RSS
Cite this brief
Drug Landscape (2026). Arthcal BAKUCHIOL FACE SERUM — Competitive Intelligence Brief. https://druglandscape.com/ci/bakuchiol. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab